Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-11 of 11
1-11 of 11
Filter
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Jerome Julian Grove
Co-Founder at The Physician's Choice CBD
alprazolam, alternative medicine, amitriptyline, analgesic, anesthesia, antihypertensive drug, arthritis, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, cancer, cannabinoid, carisoprodol, chiropractic, complex regional pain syndrome, crohn's disease, cyclobenzaprine, depression (mood), diabetic neuropathy, diarrhea, diazepam, diclofenac, dose (biochemistry), entourage effect, fentanyl, forecoxa, gabapentin, gastrointestinal disease, general surgery, harm reduction, heroin, ibuprofen, ileostomy, inflammatory bowel disease, lorazepam, medical cannabis, medical prescription, medication, meloxicam, methadone, muscle relaxant, naproxen, opiate, opioid, opioid epidemic in the united states, opioid use disorder, over-the-counter drug, oxycodone/paracetamol, pain management, paracetamol, paresthesia, peripheral neuropathies, peripheral neuropathy, pharmacology, pregabalin, psychoactive drug, rheumatology, route of administration, substance dependence, systemic lupus erythematosus, tapenade, terminal illness, tetrahydrocannabinol, therapeutic index, tramadol, ulcerative colitis
Karyemaitre Aliffe
Charlotte's Web
addiction, alternative medicine, analgesic, anesthesia, antihypertensive drug, benzodiazepine, big data, brand, caffeine, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, craft brewery and microbrewery, crohn's disease, customer, data, depression (mood), diarrhea, dose (biochemistry), drug, entourage effect, food, gastrointestinal disease, general surgery, goal, herb, herbal medicine, heroin, ileostomy, inflammatory bowel disease, major depressive disorder, mechanism of action, medical cannabis, medical prescription, medication, microwave, mirror, molecule, mood (psychology), mood disorder, natural product, nutrient, pain, pharmacology, phytochemistry, placebo, psychoactive drug, recreational drug use, route of administration, scientific method, sedative, social rejection, stress (biology), substance abuse, substance dependence, taste, terminal illness, tetrahydrocannabinol, tetraodontidae, thalidomide, therapeutic index, ulcerative colitis, vitamin, water, whole foods market, wine, wood
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anticoagulant, antipsychotic, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, budtender, cancer, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, certificate of analysis, depression (mood), dispensary, dopamine, dose (biochemistry), dravet syndrome, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, fibromyalgia, food and drug administration, free market, good manufacturing practice, gpr55, hair loss, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medicine, mental disorder, mental health, methotrexate, morphine, norepinephrine, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, pharmaceutical industry, pharmacology, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, randomized controlled trial, rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, serotonin, spasticities, sports medicine, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vaporizer (inhalation device), warfarin
Melanie Bone
Physician and Educator at 2nd.MD
anticoagulant, benzodiazepine, bioavailability, bleeding, cannabinoid, cannabis (drug), dose (biochemistry), edema, food and drug administration, indication (medicine), medical cannabis, morphine, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, pharmaceutical industry, physician, placebo-controlled study, rhabdomyosarcoma, spasticities, tetrahydrocannabinol, therapeutic index, warfarin
1
1-11 of 11